WALTHAM, Mass., Oct. 2 /PRNewswire-FirstCall/ -- Inverness Medical Innovations, Inc. (AMEX:IMA) and HemoSense Corporation (AMEX:HEM) today announced that the waiting period required under the...
WALTHAM, Mass., Aug. 6 /PRNewswire-FirstCall/ -- Inverness Medical Innovations, Inc. (AMEX:IMA) and HemoSense, Inc. (AMEX:HEM) today announced that they have entered into a definitive agreement...
HemoSense, Inc. (AMEX:HEM) today announced that it will release financial results for the three and nine months ended June 30, 2007 after market close on Tuesday, August 7...
HemoSense, Inc. (AMEX:HEM) today announced that Jim Merselis, President and CEO, will make an investment community presentation at the 2007 FBR Growth Conference on Thursday...
HemoSense, Inc. (AMEX:HEM) today announced that it has signed an agreement with Laboratory Corporation of America? Holdings (LabCorp?) (NYSE:LH) to supply the HemoSense...
HemoSense, Inc. (AMEX:HEM) and ZyCare, Inc. today announced that Pima Heart, a cardiology practice that provides medical and surgical services in southern Arizona, will use...
HemoSense, Inc. (AMEX:HEM) ? a point of care diagnostic healthcare company that develops, manufactures and sells easy-to-use, handheld blood coagulation monitoring systems for...
HemoSense, Inc. (AMEX:HEM) today announced that it will release financial results for the fiscal 2007 second quarter ended March 31, 2007 after market close on Tuesday, May 1...
HemoSense, Inc. (AMEX:HEM) today announced it has received acknowledgement from the U.S. Food and Drug Administration (FDA) that the Company has satisfactorily addressed the...
HemoSense, Inc. (AMEX:HEM) today announced that it has signed an agreement with ManthaMed, a Canadian provider of health screening, monitoring and diagnostic testing...
期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約